Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$36,000.00

Cellular and physiological consequences of opioid receptor interactions

FY 2013-14

Summary
Opioids can activate 3 receptor subtypes (mu, delta, and kappa opioid receptors; MOPRs, DOPRs, KOPRs). It has been shown over the years that different MOPR agonists do not necessarily activate a given signaling cascade with identical efficacy. In fact, rather than operating as toggle switches limited to turn pre-selected signalling cascades ''on'' or ''off'' indiscriminately (i.e. the old dogma of one ligand, one receptor and one efficacy), G protein-coupled receptors (GPCRs) were instead shown to behave as communication hubs that regulate different subsets of signalling modes that can be specifically modulated with distinct effects. This novel paradigm is called ligand-biased signalling or, more appropriate for this research program, functional selectivity. We propose that modulation of heterologous GPCR interactions emerges as an attractive way to bias the signaling cascades of a given agonist as well as the effects typically associated to a receptor. The long term objective of my research program is therefore to characterize the cellular mechanisms of opioid receptor interactions and to study the functional consequences of oligomerization. More specifically, we will study 1) the mechanisms involved in MOPR/DOPR interactions in vivo and 2) the signaling cascades associated with MOPR/DOPR oligomers. Since GPCR oligomerization emerges as a new way to selectively control the cellular and physiological responses of GPCRs, this research program thus has a great potential to extend the concept of functional selectivity, currently limited to ligands, to GPCR interactions and to the development of new molecules to highlight the role of GPCR oligomers.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
341398-2013
Name nom
Gendron, Louis
Department département
Physiologie et biophysique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5407
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Receptors
Research subject fr
Récepteurs
Partie
1
Nb partie
1
Application title
Cellular and physiological consequences of opioid receptor interactions
Keyword
NSERC
Application summary
Opioids can activate 3 receptor subtypes (mu, delta, and kappa opioid receptors; MOPRs, DOPRs, KOPRs). It has been shown over the years that different MOPR agonists do not necessarily activate a given signaling cascade with identical efficacy. In fact, rather than operating as toggle switches limited to turn pre-selected signalling cascades ''on'' or ''off'' indiscriminately (i.e. the old dogma of one ligand, one receptor and one efficacy), G protein-coupled receptors (GPCRs) were instead shown to behave as communication hubs that regulate different subsets of signalling modes that can be specifically modulated with distinct effects. This novel paradigm is called ligand-biased signalling or, more appropriate for this research program, functional selectivity. We propose that modulation of heterologous GPCR interactions emerges as an attractive way to bias the signaling cascades of a given agonist as well as the effects typically associated to a receptor. The long term objective of my research program is therefore to characterize the cellular mechanisms of opioid receptor interactions and to study the functional consequences of oligomerization. More specifically, we will study 1) the mechanisms involved in MOPR/DOPR interactions in vivo and 2) the signaling cascades associated with MOPR/DOPR oligomers. Since GPCR oligomerization emerges as a new way to selectively control the cellular and physiological responses of GPCRs, this research program thus has a great potential to extend the concept of functional selectivity, currently limited to ligands, to GPCR interactions and to the development of new molecules to highlight the role of GPCR oligomers.
Université de Sherbrooke - $36,000 Grant (2013-14) | Canada Spends